Latest News and Events

GeoVax Reports Progress with Hemorrhagic Fever Vaccine Program
Vaccine to Address Four Major Hemorrhagic Fever Viruses – Ebola, Sudan, Marburg, and Lassa; VLP P...
Continue Reading...
GeoVax Announces Filing of Investigational New Drug Application for HIV Human Clinical Trial
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced toda...
Continue Reading...
GeoVax Awarded NIH Grant for HIV Vaccine Program
Supports Development of a Vaccine to Prevent Clade C HIV Prevalent in the Developing World GeoVax...
Continue Reading...